Vol 5, No 21 (November 2017): Annals of Translational Medicine

Review Article

Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials
Jing Hu, Shuo Liu, Weihong Liu, Huina Zhang, Jing Chen, Hongcai Shang
An innovative robotic platform for magnetically-driven painless colonoscopy
Federico Bianchi, Gastone Ciuti, Anastasios Koulaouzidis, Alberto Arezzo, Danail Stoyanov, Sebastian Schostek, Calogero Maria Oddo, Arianna Menciassi, Paolo Dario
A global perspective on capsule endoscopy
Tanja Nowak

Case Report

Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better?
Jury Brandolini, Luca Bertolaccini, Alessandro Pardolesi, Piergiorgio Solli

Editorial

EGFR mutation positive non-small cell lung cancer: can we identify predictors of benefit from immune checkpoint inhibitors
Ying Wang, Peter Ellis
Eravacycline for treatment of complicated intra-abdominal infections: the fire is not ignited!
Patrick M. Honore, Herbert D. Spapen
Radiotherapy treatment strategies for squamous cell carcinoma of the cervical oesophagus: moving toward better outcomes
Pierfrancesco Franco, Francesca Arcadipane, Paolo Strignano, Renato Romagnoli, Umberto Ricardi
Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussion
Jo Raskin, Annelies Janssens, Jan P. Van Meerbeeck
Towards a comprehensive framework for cell-free DNA analysis: lessons from TRACERx
Bryan C. Ulrich, Nicolas Guibert
Fasting and engineered diets as powerful tool in the medical practice: an old approach in the new era
Concetta Panebianco, Adele Potenza, Valerio Pazienza
Remote home monitoring to identify and prevent diabetic foot ulceration
P. Andrew Crisologo, Lawrence A. Lavery
The role of foot collateral vessels on angiosome-oriented revascularization
César Varela, Francisco Acín, Joaquin De Haro, Ignacio Michel
Increased cancer-specific mortality in individuals developing mental disorders after cancer diagnosis: biomedical factors versus psychosocial support
Siran M. Koroukian, Martha Sajatovic
Alectinib can replace crizotinib as standard first-line therapy for ALK-positive lung cancer
Takehiro Uemura, Toyoaki Hida
Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay
Jean-Pierre Routy, Vikram Mehraj

Big-data Clinical Trial Column

Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial
Zhongheng Zhang, Haoyang Zhang, Mahesh Kumar Khanal